# Metabolic Effects of the Cancer Metastasis Modulator MEMO1

**Authors:** Marziyeh Ghanbarian, Natalia Dolgova, Frederick S. Vizeacoumar, Franco J. Vizeacoumar, Deborah Michel, Anas El-Aneed, Oleg Y. Dmitriev

PMC · DOI: 10.3390/metabo15040277 · Metabolites · 2025-04-17

## TL;DR

This study shows that MEMO1, a protein involved in cancer metastasis, affects the TCA cycle in breast cancer cells, with its effects depending on iron levels.

## Contribution

The study reveals a novel iron-dependent role of MEMO1 in regulating TCA cycle metabolites in breast cancer cells.

## Key findings

- Knockdown of ACO2 and OGDH inhibits cell proliferation, highlighting the TCA cycle's importance in cancer cell metabolism.
- MEMO1 knockout increases α-ketoglutarate and citrate levels regardless of iron availability.
- Fumarate, malate, and glutamate levels rise in MEMO1 knockout cells under low iron conditions.

## Abstract

Background/Objectives: Cancer cells often display altered energy metabolism. In particular, expression levels and activity of the tricarboxylic acid cycle (TCA cycle) enzymes may change in cancer, and dysregulation of the TCA cycle is a frequent hallmark of cancer cell metabolism. MEMO1, a modulator of cancer metastasis, has been shown to bind iron and regulate iron homeostasis in the cells. MEMO1 knockout changed mitochondrial morphology and iron content in breast cancer cells. Our previous genome-wide analysis of MEMO1 genetic interactions across multiple cancer cell lines revealed that gene sets involved in mitochondrial respiration and the TCA cycle are enriched among the gain-of-function interaction partners of MEMO1. Based on these findings, we measured the TCA cycle metabolite levels in breast cancer cells with varying levels of MEMO1 expression. Methods: ShRNA knockdown assay was performed to test essentiality of key TCA cycle enzymes. TCA metabolites were quantified using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in MDA-MB-231 (high MEMO1), M67-2 (MEMO1 knockdown), and M67-9 (MEMO1 knockout) cells under iron-depleted, basal iron, and iron-supplemented conditions. Results:
ACO2 and OGDH knockdowns inhibit cell proliferation, indicating an essential role of the TCA cycle in MDA-MB-231 metabolism. α-Ketoglutarate and citrate levels exhibited an inverse relationship with MEMO1 expression, increasing significantly in MEMO1 knockout cells regardless of iron availability. In contrast, fumarate, malate, and glutamate levels were elevated in MEMO1 knockout cells specifically under low iron conditions, suggesting an iron-dependent effect. Conclusions: Overall, our results indicate that MEMO1 plays a role in regulating the TCA in cancer cells in an iron-dependent manner.

## Linked entities

- **Genes:** MEMO1 (mediator of cell motility 1) [NCBI Gene 51072], ACO2 (aconitase 2) [NCBI Gene 50], OGDH (oxoglutarate dehydrogenase) [NCBI Gene 4967]
- **Chemicals:** citrate (PubChem CID 31348), fumarate (PubChem CID 5460307), malate (PubChem CID 525), glutamate (PubChem CID 611), iron (PubChem CID 23925)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** breast cancer (MESH:D001943), Cancer (MESH:D009369)
- **Chemicals:** tricarboxylic acid (MESH:D014233), fumarate (MESH:D005650), alpha-Ketoglutarate (MESH:D007656), glutamate (MESH:D018698), iron (MESH:D007501), MEMO1 (-), TCA (MESH:D014238), citrate (MESH:D019343), malate (MESH:C030298)
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), M67-2 — Mus musculus (Mouse), Hybridoma (CVCL_B7QY)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12029338/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12029338/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12029338/full.md

---
Source: https://tomesphere.com/paper/PMC12029338